I am Professor of Primary Care and Head of the Department of Primary Care and Public Health at Imperial College London. I am also a GP Principal in Clapham, London.
I agree Jaimie. These issues should have been resolved before plans for establishing primary care networks were published.
Do we know how much the contract was for and how the "pound per patient" compares with that for a typical GMS practice?
Good luck with your recruitment campaign Dave.
Good luck with trying to recruit more staff Dave. Areas like Pembroke Dock need better staffed primary care services.
Thanks - a very informative article.
Thank you for your article - very informative.
I wonder how much the GMC paid Sir Robert Francis for that advice?
Good points Jaimie.
Very interesting work. Well done Dr Vasant, Dr Salau and Dr Arumugaraasah.
Many thanks Dr Karavitaki.
Once again, when a private sector company pulls out of providing an essential medical service at short notice, it is the NHS which has to step in to keep services running.
Many thanks for your article.
The advice from the MDDUS medico-legal adviser Dr Roopinder Brar does not make any sense. The responsibility for pre-operative MRSA screening relies with the provider carrying out the operation. The hospital can’t stop doing this screening unilaterally and try to shift the work onto general practice.
Good advice Jaimie.
These services should never have been transferred to local government in 2013 (in England). They should have remained the responsibility of the NHS.
An excellent article.
Thank you for your article Surina.
Thanks. Some very useful learning points.
t’s a small observational study (570 participants) and so it is difficult to draw firm conclusions. The findings are though in line with those from other observational studies of blood pressure in older people.
Clinical guidelines don’t generally provide specific advice on treating high blood pressure in the very elderly (85 and over), partly because there is limited evidence from clinical trials in this group. Clinicians should therefore tailor their treatment in the very elderly for each individual, taking into account factors such as frailty, cognitive function and predicted life expectancy.
It’s an area where we need further research and clearer guidance from bodies such as NICE.